Home / Drug shortages / Diltiazem Hydrochloride Injection

Diltiazem Hydrochloride Injection — FDA Drug Shortage

To Be Discontinued — Hospira, Inc., a Pfizer Company

The FDA lists a drug shortage record for Diltiazem Hydrochloride Injection (injection) from Hospira, Inc., a Pfizer Company with status To Be Discontinued. The shortage was first posted on 01/05/2026.

Shortage Details

Status
To Be Discontinued
Company
Hospira, Inc., a Pfizer Company
Package NDC
0409-4350-03
Dosage Form
Injection
Presentation
Diltiazem Hydrochloride, Injection, 100 mg Single Dose ADD-Vantage® Glass Vial (NDC 0409-4350-03)
Initial Posting
01/05/2026
Revised Date

FDA data resources